{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-063325","form_type":"8-K","ticker":"TRDA","cik":"0001689375","company_name":"Entrada Therapeutics, Inc.","filed_at":"2026-05-18T22:32:23+00:00","discovered_at":"2026-05-19T10:05:00.229338+00:00","generated_at":"2026-05-19T10:07:34.713351+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Entrada updates corporate presentation; no specific financial or pipeline details disclosed","bullets":["Filing includes updated corporate presentation (Exhibit 99.1) for use in investor meetings.","Presentation dated May 2026 was furnished under Regulation FD.","No specific changes in financial guidance, pipeline milestones, or leadership disclosed in the filing excerpt.","The full presentation content was not provided in the filing text available for analysis."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-063325","json":"https://secwatch.observer/filing/0001104659-26-063325.json","markdown":"https://secwatch.observer/filing/0001104659-26-063325.md","text":"https://secwatch.observer/filing/0001104659-26-063325.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1689375/000110465926063325/0001104659-26-063325-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1689375/000110465926063325/tm2614944d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T10:07:34.713351+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}